Society guideline links: Neonatal jaundice

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Pediatric liver disease".)

International

●World Health Organization (WHO): Recommendations on maternal and newborn care for a positive postnatal experience (2022)

●Academy of Breastfeeding Medicine (ABM): Clinical protocol #22 − Guidelines for management of jaundice in the breastfeeding infant 35 weeks or more of gestation, revised (2017)

●WHO: Recommendations on newborn health (2017)

Canada

●Choosing Wisely Canada: Don't delay testing for total and conjugated (direct) bilirubin in any newborn with persistent jaundice beyond 2 weeks of age (2021)

●Canadian Paediatric Society (CPS): Guidelines for detection, management, and prevention of hyperbilirubinemia in term and late preterm newborn infants (2007, reaffirmed 2018)

●North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN): Guideline for the evaluation of cholestatic jaundice in infants (2017)

United States

●American College of Obstetricians and Gynecologists (ACOG): Committee opinion on delayed umbilical cord clamping after birth (2017, reaffirmed 2023)

●American Academy of Pediatrics (AAP): Clinical practice guideline for the management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation, revision (2022)